Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,176
datasets available to search
ShareScore release 0.9.0
Dataset results
1,176 results for “ulcerative colitis”
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
ClinicalTrials.gov study NCT04033445. IPD Sharing: YES. Countries: 34. Publications: 3.
Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis
ClinicalTrials.gov study NCT00713310. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
ClinicalTrials.gov study NCT02435992. IPD Sharing: Not stated. Countries: 30. Publications: 6.
Golimumab Utilization and Impact on Ulcerative Colitis (MK-8259-032)
ClinicalTrials.gov study NCT02092285. IPD Sharing: YES. Countries: 1. Publications: 1.
Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis
ClinicalTrials.gov study NCT02438410. IPD Sharing: Not stated. Countries: 1. Publications: 14.
VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis
ClinicalTrials.gov study NCT05156125. IPD Sharing: UNDECIDED. Countries: 14. Publications: 1.
A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
ClinicalTrials.gov study NCT03662542. IPD Sharing: Not stated. Countries: 9. Publications: 2.
A Safety and Effectiveness Study of Golimumab in Japanese Patients With Moderately to Severely Active Ulcerative Colitis.
ClinicalTrials.gov study NCT01863771. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
ClinicalTrials.gov study NCT02407236. IPD Sharing: Not stated. Countries: 23. Publications: 10.
Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis
ClinicalTrials.gov study NCT02289417. IPD Sharing: YES. Countries: 14. Publications: 1.
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
ClinicalTrials.gov study NCT01130844. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis
ClinicalTrials.gov study NCT03996369. IPD Sharing: NO. Countries: 41. Publications: 17.
A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
ClinicalTrials.gov study NCT03596645. IPD Sharing: Not stated. Countries: 11. Publications: 1.
Clinical Study of TA-650 in Pediatric Patients With Ulcerative Colitis
ClinicalTrials.gov study NCT01585155. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Abatacept in Patients With Active Ulcerative Colitis
ClinicalTrials.gov study NCT00410410. IPD Sharing: Not stated. Countries: 19. Publications: 1.
Abrilumab (AMG 181) in Adults With Moderate to Severe Ulcerative Colitis
ClinicalTrials.gov study NCT01694485. IPD Sharing: Not stated. Countries: 20. Publications: 1.
A Study of Tofacitinib in Patients With Ulcerative Colitis in Stable Remission
ClinicalTrials.gov study NCT03281304. IPD Sharing: YES. Countries: 20. Publications: 5.
A Trial of Rosiglitazone for Ulcerative Colitis
ClinicalTrials.gov study NCT00065065. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis
ClinicalTrials.gov study NCT02065622. IPD Sharing: YES. Countries: 20. Publications: 4.
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
ClinicalTrials.gov study NCT01482884. IPD Sharing: Not stated. Countries: 6. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.